Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03390114 · ClinicalTrials.gov registry record · NA

Cognitive Behavioral Therapy to Treat Insomnia in Persons With HIV Infection

A NA study of Insomnia and HIV/AIDS, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03390114: Completed NA study of Insomnia and HIV/AIDS, sponsored by Indiana University.

NCT03390114 is a NA study of Insomnia and HIV/AIDS that has completed, run by Indiana University. The registered enrollment target is 20 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03390114, a NA study of Insomnia and HIV/AIDS, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The goal of this preliminary study is to determine the efficacy of an internet-based treatment program for insomnia for HIV-infected persons.

Primary Outcome

Change in the Insomnia Severity Index (ISI) score as measured by questionnaire. The ISI score ranges from 0 to 28 with higher scores indicating greater severity in insomnia symptoms.

Conditions Studied

Interventions

  • BEHAVIORAL SHUTi

Study Locations (1)

Indiana

  • Infectious Diseases Research Center - Indianapolis

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-05-01
Est. Completion 2019-12-31
Phase NA
Indiana University

890 total trials

What the finished NCT03390114 record still lists

NCT03390114 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which SHUTi is the first listed.

NCT03390114 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT03390114 about?

NCT03390114 is a clinical study titled "Cognitive Behavioral Therapy to Treat Insomnia in Persons With HIV Infection". The goal of this preliminary study is to determine the efficacy of an internet-based treatment program for insomnia for HIV-infected persons.

What is the current status of trial NCT03390114?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-05-01. Estimated completion is 2019-12-31.

What conditions does trial NCT03390114 study?

This clinical trial studies the following conditions: Insomnia, HIV/AIDS.

What interventions are being tested in trial NCT03390114?

The interventions under investigation include: SHUTi (BEHAVIORAL).

Who is sponsoring clinical trial NCT03390114?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03390114 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03390114's enrollment target sits among peer trials

20 137th of 151 higher than 12 of 151 other Insomnia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03390114, the US trial registry maintained by the National Library of Medicine. NCT03390114 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.